广康生化 (300804.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(广康生化)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 178,058,819.17138,893,975.7293,685,931.29106,273,646.58156,157,878.04145,723,032.86156,157,379.60
 营业收入(元) 178,058,819.17138,893,975.7293,685,931.29106,273,646.58156,157,878.04145,723,032.86156,157,379.60
二、营业总成本(元) 155,892,855.08133,483,133.13102,697,856.84100,594,390.52129,117,364.16126,343,440.48124,957,733.97
 营业成本(元) 133,674,766.36103,622,116.0582,567,994.1280,788,640.59109,081,469.13109,612,766.18103,937,076.77
 研发费用(元) 4,379,916.1710,107,659.905,691,116.274,805,332.566,462,811.867,292,058.686,167,368.46
 营业税金及附加(元) 391,655.34468,812.86322,248.11293,047.11318,103.51300,171.28572,159.49
 销售费用(元) 2,057,426.671,803,099.241,153,527.591,782,360.921,347,976.162,793,978.162,234,697.68
 管理费用(元) 13,994,971.1714,311,389.6512,888,200.2211,303,748.029,010,113.2110,177,860.6710,342,334.59
 财务费用(元) 1,394,119.373,170,055.4374,770.531,621,261.322,896,890.29-3,833,394.491,704,096.98
  其中:利息费用(元) 2,266,185.832,291,924.39--1,724,483.691,051,458.29612,486.49
  其中:利息收入(元) 1,293,478.50436,580.34--13,439.13-18,357.8056,749.26
 信用减值损失(元) -3,159,352.38-1,501,605.03429,581.872,109,732.64-2,115,943.77-121,172.49-357,063.00
三、其他经营收益
 加:投资收益(元) 1,570,493.953,885,516.30-----
 资产处置收益(元) --526,910.09-----
 其他收益(元) 377,908.79289,607.10289,607.10327,607.10315,678.65447,119.95488,705.67
四、营业利润(元) 20,955,014.455,373,279.53-7,613,362.158,116,595.8025,240,248.7619,705,539.8431,331,288.30
 加:营业外收入(元) 6,175.022,000,000.2044,561.32500.005,310.002,688.3320,000.45
 减:营业外支出(元) 438,713.09800,033.59729,302.28387,066.03641,304.44359,897.031,745,818.53
五、利润总额(元) 20,522,476.386,573,246.14-8,298,103.117,730,029.7724,604,254.3219,348,331.1429,605,470.22
 减:所得税费用(元) 2,884,165.12-3,434,294.44-103,131.111,205,350.872,870,088.691,644,702.824,045,669.96
六、净利润(元) 17,638,311.2610,007,540.58-8,194,972.006,524,678.9021,734,165.6317,703,628.3225,559,800.26
(一)按经营持续性分类
  持续经营净利润(元) 17,638,311.2610,007,540.58-8,194,972.006,524,678.9021,734,165.6317,703,628.3225,559,800.26
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 17,670,252.5610,007,540.58-8,194,972.006,524,678.9021,734,165.6317,703,628.3225,559,800.26
  少数股东损益(元) -31,941.30------
 扣除非经常性损益后的净利润(元) 16,392,710.495,342,398.07-7,893,553.126,578,693.9922,006,652.2017,766,599.7426,613,800.26
七、每股收益
 一、基本每股收益(元) 0.240.13-0.180.120.390.320.46
 二、稀释每股收益(元) 0.240.12-0.170.120.390.320.46
九、综合收益总额(元) 17,638,311.2610,007,540.58-8,194,972.006,524,678.9021,734,165.6317,703,628.3225,559,800.26
 归属于母公司所有者的综合收益总额(元) 17,670,252.5610,007,540.58-8,194,972.006,524,678.9021,734,165.6317,703,628.3225,559,800.26
 归属于少数股东的综合收益总额(元) -31,941.30------
公告日期 2024-04-262024-04-262023-10-262023-08-292023-06-052023-01-302023-06-05
审计意见(境内) 标准无保留意见标准无保留意见

前瞻产业研究院